Nationwide Fund Advisors’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-380,713
| Closed | -$4.68M | – | 2796 |
|
|
2017
Q3 | $4.68M | Buy |
380,713
+254,720
| +202% | +$3.13M | 0.02% | 1048 |
|
|
2017
Q2 | $1.06M | Buy |
125,993
+14,254
| +13% | +$119K | ﹤0.01% | 1751 |
|
|
2017
Q1 | $999K | Sell |
111,739
-27,528
| -20% | -$246K | ﹤0.01% | 1746 |
|
|
2016
Q4 | $1.22M | Buy |
139,267
+11,479
| +9% | +$101K | 0.01% | 1662 |
|
|
2016
Q3 | $863K | Buy |
127,788
+36,661
| +40% | +$248K | ﹤0.01% | 1875 |
|
|
2016
Q2 | $324K | Hold |
91,127
| – | – | ﹤0.01% | 2378 |
|
|
2016
Q1 | $269K | Sell |
91,127
-1,400
| -2% | -$4.13K | ﹤0.01% | 2404 |
|
|
2015
Q4 | $390K | Buy |
92,527
+984
| +1% | +$4.15K | ﹤0.01% | 2242 |
|
|
2015
Q3 | $417K | Hold |
91,543
| – | – | ﹤0.01% | 2220 |
|
|
2015
Q2 | $660K | Sell |
91,543
-4,341
| -5% | -$31.3K | ﹤0.01% | 2088 |
|
|
2015
Q1 | $707K | Buy |
95,884
+499
| +0.5% | +$3.68K | ﹤0.01% | 2076 |
|
|
2014
Q4 | $451K | Sell |
95,385
-2,093
| -2% | -$9.9K | ﹤0.01% | 2238 |
|
|
2014
Q3 | $348K | Sell |
97,478
-432
| -0.4% | -$1.54K | ﹤0.01% | 2418 |
|
|
2014
Q2 | $446K | Buy |
97,910
+2,157
| +2% | +$9.83K | ﹤0.01% | 2325 |
|
|
2014
Q1 | $450K | Sell |
95,753
-19,382
| -17% | -$91.1K | ﹤0.01% | 2104 |
|
|
2013
Q4 | $577K | Buy |
115,135
+2,327
| +2% | +$11.7K | ﹤0.01% | 2183 |
|
|
2013
Q3 | $702K | Buy |
112,808
+24,078
| +27% | +$150K | ﹤0.01% | 2042 |
|
|
2013
Q2 | $403K | Buy |
+88,730
| New | +$403K | ﹤0.01% | 2115 |
|